Questions & explanations
1. Why is it important to tell apart IgE-mediated from non-IgE-mediated occupational asthma for treatment and prevention?
Telling them apart helps choose the right treatment. For IgE-mediated asthma, avoiding the substance is key, and medicines like antihistamines or allergy shots (immunotherapy) might help. For non-IgE-mediated asthma, avoidance is also important, but anti-inflammatory medicines like inhaled corticosteroids are often needed to control the slow inflammation. Also, the diagnosis affects workplace changes: IgE-mediated may require removing the person from any exposure, while non-IgE-mediated might allow some low exposure with protection. Knowing the mechanism also helps predict how fast symptoms appear after exposure, which is useful for the worker to recognize and avoid triggers.
2. Compare the skin test results in IgE-mediated versus non-IgE-mediated occupational asthma.
In IgE-mediated occupational asthma, skin prick tests with the suspected substance are usually positive. This means a small amount of the substance placed on the skin causes a red, itchy bump within 15-20 minutes, showing that IgE antibodies are present. In non-IgE-mediated occupational asthma, skin prick tests are typically negative because there is no IgE involved. However, patch tests that look for delayed reactions (after 48-72 hours) may be positive in some non-IgE-mediated cases, especially for substances like metals. So, a positive skin prick test points to IgE-mediated, while a negative skin prick test does not rule out non-IgE-mediated asthma.
3. What are diisocyanates and why do they cause occupational asthma?
Diisocyanates are chemicals used to make polyurethane products like foams, paints, and adhesives. They are found in many workplaces such as spray painting, insulation, and manufacturing. They cause occupational asthma because they are strong irritants and can also trigger an allergic reaction in the airways. When a person breathes in diisocyanate vapors or sprays, the immune system may become sensitized, meaning it starts to see the chemical as harmful. After sensitization, even very small amounts can cause asthma symptoms like coughing, wheezing, and chest tightness. Diisocyanate asthma is one of the most common types of occupational asthma.
4. How does the treatment for silo filler's disease differ from that for a typical asthma attack?
Silo filler's disease is caused by nitrogen dioxide (NO₂) inhalation, which damages lung tissue and causes fluid buildup (pulmonary edema). Treatment focuses on giving high concentrations of oxygen and, in severe cases, using a ventilator to help breathing. Steroids may be given to reduce inflammation. In contrast, an asthma attack involves airway narrowing due to muscle spasm and swelling, and is treated with inhaled bronchodilators (like albuterol) to open airways, plus steroids. The key difference is that silo filler's disease requires aggressive oxygen therapy and possibly mechanical ventilation, while asthma responds to bronchodilators.
5. What is the main treatment for diisocyanate-induced asthma, and how does it differ from treating other types of asthma?
The main treatment is complete and permanent removal from any further exposure to diisocyanates. Unlike other asthma where medicines can control symptoms while continuing exposure, diisocyanate asthma often gets worse with continued exposure, even with medication. Medicines like inhaled corticosteroids and bronchodilators are used to control symptoms, but they do not stop the disease from progressing if exposure continues. Workers may need to change jobs or use protective equipment that completely prevents inhalation. Early removal from exposure can lead to improvement, but some people have permanent asthma even after stopping exposure.
6. Why is it important to correctly classify a disability as total or partial?
Correct classification determines the amount and duration of benefits the worker receives. Total disability provides lifelong wage replacement, while partial disability provides limited benefits. Misclassification can lead to underpayment or overpayment. For example, if a totally disabled worker is wrongly classified as partially disabled, they may not get enough money to live on. If a partially disabled worker is classified as totally disabled, the employer or insurer pays more than necessary. Accurate classification ensures fair compensation based on the worker's actual ability to work. It also affects the employer's insurance costs.
7. How is diisocyanate-induced asthma diagnosed?
Diagnosis starts with a detailed history of work exposure to diisocyanates and asthma symptoms that get better on days off or holidays. Lung function tests, like spirometry, show reversible airway blockage. A methacholine challenge test can confirm airway hyperresponsiveness. Specific tests include measuring diisocyanate-specific IgE or IgG antibodies in the blood, but these are not always positive. The best test is a specific inhalation challenge (SIC) with diisocyanates, but it is risky and done only in specialized centers. A positive SIC confirms the diagnosis. Sometimes, a trial of avoiding exposure and monitoring symptoms helps.
8. Describe the steps of a specific inhalation challenge (SIC) test for occupational asthma.
First, the patient stops taking asthma medicines for a safe period. On the test day, the doctor measures the patient's lung function with a spirometer, which checks how much air they can blow out. The patient then inhales a placebo, like a harmless powder, to see if there is a reaction. If lung function stays normal, the patient inhales a very low dose of the suspected workplace substance. The doctor repeats lung function tests every few minutes for the first hour, then every hour for up to 8 hours. A drop in lung function of 20% or more from the starting value is a positive test, meaning the substance likely causes the asthma.
9. How can you tell work-exacerbated asthma apart from occupational asthma?
The main difference is that in occupational asthma, the work substance causes the asthma to start in a person who did not have asthma before. In work-exacerbated asthma, the person already had asthma, and work makes it worse. A careful history can help: if the person had asthma symptoms before starting the job, it is likely work-exacerbated. Also, in occupational asthma, symptoms often get better when away from work for days or weeks, while in work-exacerbated asthma, symptoms may improve but the person still has asthma. Specific allergy tests may be positive in occupational asthma but not in work-exacerbated asthma.
10. How is hot tub lung diagnosed, and what is the most important step in treatment?
Diagnosis is based on a history of hot tub use, symptoms, chest imaging, and sometimes a lung biopsy that shows inflammation called granulomas. A special stain of lung tissue or fluid can show MAC bacteria. Blood tests may show antibodies against MAC, but they are not always reliable. The most important treatment is to stop using the hot tub completely. Unlike a true MAC infection, antibiotics are usually not needed because the disease is an allergic reaction, not an active infection. Symptoms often go away within weeks after avoiding the hot tub. In severe cases, corticosteroids may be given to reduce inflammation.
11. Compare a wage loss offset with a situation where there is no offset and the worker receives full benefits plus wages.
Without an offset, a worker could receive both full disability benefits and wages from a new job, potentially earning more than before the injury. For example, if pre-injury wage was $1,000 and benefits are $600, plus a new job paying $600, total is $1,200, which is more than before. This could discourage the worker from seeking higher-paying work or returning to full capacity. With an offset, benefits are reduced so total income does not exceed pre-injury wages. The offset encourages work by ensuring that returning to work always increases total income, but not excessively. It makes the system fairer for everyone.
12. Compare the risk of pulmonary hypertension from anorexigens versus other causes like scleroderma.
Anorexigen-induced pulmonary hypertension is often reversible if the drug is stopped early, while pulmonary hypertension from scleroderma (a connective tissue disease) is usually progressive and not reversible. The risk from anorexigens is dose- and duration-dependent, meaning higher doses and longer use increase risk. In contrast, scleroderma-related pulmonary hypertension is driven by autoimmune inflammation and fibrosis. Both conditions cause similar symptoms like shortness of breath, but treatment differs: anorexigen-induced cases may improve with drug withdrawal, while scleroderma requires specific therapies.